MICHELE KREFT: Open Payments
NPI 1477821445 · GREEN BAY, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 8 payments from 7 companies in 2025. Trend: 2023 $1,276 · 2024 $205 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $220 |
| Gilead Sciences, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $112 |
| AstraZeneca Pharmaceuticals LP | 1 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $109 |
| Exact Sciences Corporation | 1 | $105 |
| Lilly USA, LLC | 1 | $95 |
Products named: VRAYLAR, Epclusa, INGREZZA, FASENRA, CAPLYTA, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across WI — which companies pay providers there.
